Thursday, October 17, 2024
No menu items!
HomeLonza to buy back $2.17 billion worth of shares, backs mid-term growthFILE PHOTO: A logo is pictured on the Ibex building

FILE PHOTO: A logo is pictured on the Ibex building

FILE PHOTO: A logo is pictured on the Ibex building of Lonza, where the Moderna mRNA coronavirus disease (COVID-19) vaccine will be produced, in Visp, Switzerland, September 29, 2020. REUTERS/Denis Balibouse/File Photo
FILE PHOTO: Logo of Swiss contract drug maker Lonza is
- Advertisment -

Most Read

© Newspaper WordPress Theme by TagDiv